Position in BCAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,288
-$40,109 QoQ
Shares Held
39,056
-52.2% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Derivatives in BCAB
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$7,801
PutShares
13,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,924,448 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in BCAB
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,288 | 39,056 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $46,397 | 81,687 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $173,777 | 252,583 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $29,629 | 74,823 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $11,698 | 33,713 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $126,610 | 214,231 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $7,801 | 13,200 | Put | Other | 2025-02-14 | |
| 2024-09-30 | $316,317 | 179,726 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $232,164 | 169,463 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $306,789 | 89,183 | Shares | Defined | 2024-05-07 | |
| 2024-03-31 | $67,768 | 19,700 | Call | Defined | 2024-05-07 | |
| 2023-12-31 | $145,949 | 59,329 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $83,300 | 49,000 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $214,617 | 126,246 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $347,001 | 115,667 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $59,764 | 22,300 | Call | Defined | 2023-05-16 | |
| 2023-03-31 | $688,665 | 256,965 | Shares | Defined | 2023-05-16 | |
| 2023-03-31 | $71,288 | 26,600 | Put | Defined | 2023-05-16 | |
| 2022-12-31 | $240,075 | 29,100 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $1,878,731 | 227,725 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $590,700 | 71,600 | Put | Defined | 2023-02-14 | |
| 2022-09-30 | $874,720 | 113,600 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $550,257 | 71,462 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $489,720 | 63,600 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $61,275 | 21,500 | Put | Defined | 2022-08-15 | |
| 2022-06-30 | $347,617 | 121,971 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $376,500 | 75,300 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $521,475 | 104,295 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $285,500 | 57,100 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $577,337 | 29,411 | Shares | Defined | 2022-04-05 | |
| 2021-09-30 | $727,020 | 24,695 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $369,935 | 8,729 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||